- Home
- AMBC vs MREO Comparison
AMBC vs MREO Comparison
Compare AMBC & MREO Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- AMBC
- MREO
- Stock Information
- Founded
- AMBC 1991
- MREO 2015
- Country
- AMBC United States
- MREO United Kingdom
- Employees
- AMBC N/A
- MREO N/A
- Industry
- AMBC Property-Casualty Insurers
- MREO Biotechnology: Pharmaceutical Preparations
- Sector
- AMBC Finance
- MREO Health Care
- Exchange
- AMBC Nasdaq
- MREO Nasdaq
- Market Cap
- AMBC 566.2M
- MREO 577.6M
- IPO Year
- AMBC 1991
- MREO N/A
- Fundamental
- Price
- AMBC $11.28
- MREO $4.09
- Analyst Decision
- AMBC Strong Buy
- MREO Strong Buy
- Analyst Count
- AMBC 2
- MREO 4
- Target Price
- AMBC $17.00
- MREO $7.50
- AVG Volume (30 Days)
- AMBC 456.9K
- MREO 530.1K
- Earning Date
- AMBC 11-12-2024
- MREO 11-18-2024
- Dividend Yield
- AMBC N/A
- MREO N/A
- EPS Growth
- AMBC N/A
- MREO N/A
- EPS
- AMBC 1.58
- MREO N/A
- Revenue
- AMBC $338,000,000.00
- MREO $1,000,000.00
- Revenue This Year
- AMBC N/A
- MREO $16.39
- Revenue Next Year
- AMBC N/A
- MREO $9.44
- P/E Ratio
- AMBC $7.25
- MREO N/A
- Revenue Growth
- AMBC 5.63
- MREO N/A
- 52 Week Low
- AMBC $10.12
- MREO $1.86
- 52 Week High
- AMBC $18.45
- MREO $5.02
- Technical
- Relative Strength Index (RSI)
- AMBC 46.50
- MREO 42.69
- Support Level
- AMBC $10.87
- MREO $3.98
- Resistance Level
- AMBC $11.97
- MREO $4.21
- Average True Range (ATR)
- AMBC 0.36
- MREO 0.18
- MACD
- AMBC -0.03
- MREO -0.03
- Stochastic Oscillator
- AMBC 33.61
- MREO 14.86
About AMBC Ambac Financial Group Inc.
Ambac Financial Group Inc is a financial services holding company. The business operations of the company include Legacy Financial Guarantee Insurance, Specialty Property and Casualty Insurance and Insurance Distribution. The Company has three reportable segments namely Legacy Financial Guarantee Insurance, Specialty Property and Casualty Insurance and Insurance Distribution. Majority of revenues are earned from Legacy Financial Guarantee Insurance segment.
About MREO Mereo BioPharma Group plc
Mereo BioPharma Group PLC is a United Kingdom (U.K.) based biopharmaceutical company focused on the development of innovative therapeutics for rare diseases. The Company has developed a portfolio of late-stage clinical product candidates, and its two rare disease product candidates are setrusumab for the treatment of osteogenesis imperfecta (OI) and alvelestat primarily for the treatment of severe alpha-1 antitrypsin deficiency-associated lung disease (AATD-LD).